Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,351 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $332.31 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $208.75 | 2 | $0 (2023) |
| UCB, Inc. | $185.42 | 9 | $0 (2024) |
| Stryker Corporation | $139.17 | 3 | $0 (2024) |
| Genentech USA, Inc. | $137.05 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $103.61 | 1 | $0 (2019) |
| Akcea Therapeutics, Inc. | $62.56 | 1 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $60.00 | 1 | $0 (2023) |
| Boston Scientific Corporation | $46.72 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $30.69 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.59 | 5 | Stryker Corporation ($37.23) |
| 2023 | $405.10 | 13 | UCB, Inc. ($124.51) |
| 2022 | $194.77 | 3 | Medtronic, Inc. ($156.10) |
| 2021 | $318.60 | 3 | Medtronic, Inc. ($142.82) |
| 2020 | $62.56 | 1 | Akcea Therapeutics, Inc. ($62.56) |
| 2019 | $240.66 | 2 | Genentech USA, Inc. ($137.05) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | Stryker Corporation | TREVO (Device) | Food and Beverage | In-kind items and services | $37.23 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 07/17/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 04/15/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: WATCHMAN_IC | ||||||
| 03/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Neurology | ||||||
| 01/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Neurology | ||||||
| 12/13/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Neurology | ||||||
| 12/08/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Neurology | ||||||
| 09/13/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Neurology | ||||||
| 08/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $120.50 | General |
| Category: Rare Disease | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Rare Disease | ||||||
| 06/28/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Neurology | ||||||
| 06/26/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: WATCHMAN_IC | ||||||
| 05/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
| 02/01/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Neurology | ||||||
| 01/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GAMMAGARD LIQUID (Biological) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2022 | Stryker Corporation | SURPASS EVOLVE (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: FLOW DIVERTER | ||||||
| 09/27/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Neurology | ||||||
| 05/16/2022 | Medtronic, Inc. | SOLITAIRE X (Device) | Food and Beverage | In-kind items and services | $156.10 | General |
| Category: Stents | ||||||
| 11/10/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $88.25 | General |
| Category: Immunology | ||||||
| 10/18/2021 | Medtronic, Inc. | Solitaire (Device) | Food and Beverage | In-kind items and services | $142.82 | General |
| Category: Stents | ||||||
| 10/12/2021 | Stryker Corporation | TREVO (Device) | Food and Beverage | In-kind items and services | $87.53 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 01/18/2020 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $62.56 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 213 | 382 | $66,061 | $26,831 |
| 2022 | 6 | 343 | 543 | $91,707 | $35,691 |
| 2021 | 9 | 302 | 483 | $70,120 | $28,457 |
| 2020 | 9 | 387 | 585 | $96,288 | $38,802 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 207 | $28,359 | $12,497 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 63 | $23,877 | $8,297 | 34.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 41 | 66 | $4,950 | $2,530 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 31 | $5,890 | $2,197 | 37.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 15 | $2,985 | $1,311 | 43.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 108 | 251 | $34,719 | $13,633 | 39.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 88 | $33,922 | $13,360 | 39.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 86 | 138 | $10,350 | $4,122 | 39.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 41 | $8,188 | $2,853 | 34.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 12 | $3,141 | $1,048 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 13 | $1,387 | $676.35 | 48.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 75 | 145 | $20,155 | $8,095 | 40.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 43 | $16,727 | $6,687 | 40.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 90 | 187 | $14,025 | $5,558 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 31 | $8,122 | $3,208 | 39.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $3,211 | $1,385 | 43.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 16 | $3,200 | $1,205 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 13 | $1,950 | $1,013 | 52.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 13 | $1,300 | $686.14 | 52.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 12 | 22 | $1,430 | $619.96 | 43.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 99 | 103 | $40,067 | $16,204 | 40.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 108 | 246 | $18,450 | $7,557 | 41.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 81 | 129 | $17,931 | $7,202 | 40.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 22 | $5,764 | $2,267 | 39.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 16 | 16 | $5,200 | $2,116 | 40.7% |
About Dr. Timothy Coleman, MD
Dr. Timothy Coleman, MD is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730382128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Coleman, MD has received a total of $1,351 in payments from pharmaceutical and medical device companies, with $129.59 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,351).
As a Medicare-enrolled provider, Coleman has provided services to 1,245 Medicare beneficiaries, totaling 1,993 services with total Medicare billing of $129,782. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Lexington, KY
- Active Since 06/06/2007
- Last Updated 12/02/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1730382128
Products in Payments
- Briviact (Drug) $185.42
- SOLITAIRE X (Device) $156.10
- Solitaire (Device) $142.82
- TREVO (Device) $124.76
- ULTOMIRIS (Biological) $120.50
- AUSTEDO (Drug) $103.61
- Soliris (Drug) $88.25
- TEGSEDI (Drug) $62.56
- GAMMAGARD LIQUID (Biological) $60.00
- WATCHMAN Access System (Device) $46.72
- LINQ II (Device) $33.39
- XARELTO (Drug) $30.69
- BOTOX (Biological) $25.46
- ANDEXXA (Biological) $19.54
- SURPASS EVOLVE (Device) $14.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615